149 related articles for article (PubMed ID: 9270574)
21. Proton magnetic resonance spectroscopy (1H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patients.
Lucetti C; Del Dotto P; Gambaccini G; Bernardini S; Bianchi MC; Tosetti M; Bonuccelli U
Neurol Sci; 2001 Feb; 22(1):69-70. PubMed ID: 11487206
[TBL] [Abstract][Full Text] [Related]
22. Metabolic alterations in Parkinson's disease after thalamotomy, as revealed by 1H MR spectroscopy.
Baik HM; Choe BY; Lee HK; Suh TS; Son BC; Lee JM
Korean J Radiol; 2002; 3(3):180-8. PubMed ID: 12271163
[TBL] [Abstract][Full Text] [Related]
23. A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings.
Ellis CM; Simmons A; Andrews C; Dawson JM; Williams SC; Leigh PN
Neurology; 1998 Oct; 51(4):1104-9. PubMed ID: 9781537
[TBL] [Abstract][Full Text] [Related]
24. [Proton MR spectroscopy of the brain in patients with congenital myotonic dystrophy].
Hashimoto T; Tayama M; Yoshimoto T; Miyazaki M; Harada M; Miyoshi H; Tanouchi M; Kuroda Y
No To Hattatsu; 1995 May; 27(3):177-83. PubMed ID: 7662403
[TBL] [Abstract][Full Text] [Related]
25. N-Acetylaspartate and creatine levels measured by (1)H MRS relate to recognition memory.
Ferrier CH; Alarcón G; Glover A; Koutroumanidis M; Morris RG; Simmons A; Elwes RD; Cox T; Binnie CD; Polkey CE
Neurology; 2000 Dec; 55(12):1874-83. PubMed ID: 11134388
[TBL] [Abstract][Full Text] [Related]
26. In vivo proton magnetic resonance spectroscopy of brain tumors.
Fountas KN; Kapsalaki EZ; Gotsis SD; Kapsalakis JZ; Smisson HF; Johnston KW; Robinson JS; Papadakis N
Stereotact Funct Neurosurg; 2000; 74(2):83-94. PubMed ID: 11251398
[TBL] [Abstract][Full Text] [Related]
27. [Magnetic resonance spectroscopy in Parkinson's disease and multiple system atrophy].
Aotsuka A; Shinotoh H; Hattori T
Nihon Rinsho; 1997 Jan; 55(1):249-54. PubMed ID: 9014459
[TBL] [Abstract][Full Text] [Related]
28. Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report.
Fukuzako H; Takeuchi K; Hokazono Y; Fukuzako T; Yamada K; Hashiguchi T; Obo Y; Ueyama K; Takigawa M; Fujimoto T
Psychiatry Res; 1995 Nov; 61(4):193-200. PubMed ID: 8748464
[TBL] [Abstract][Full Text] [Related]
29. Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: a proton MR spectroscopy study.
Hu MT; Taylor-Robinson SD; Chaudhuri KR; Bell JD; Morris RG; Clough C; Brooks DJ; Turjanski N
J Neurol Neurosurg Psychiatry; 1999 Jul; 67(1):20-6. PubMed ID: 10369817
[TBL] [Abstract][Full Text] [Related]
30. Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy.
Clarke CE; Lowry M; Horsman A
Mov Disord; 1997 May; 12(3):297-301. PubMed ID: 9159722
[TBL] [Abstract][Full Text] [Related]
31. Proton MR spectroscopy of cerebellitis.
Guerrini L; Belli G; Cellerini M; Nencini P; Mascalchi M
Magn Reson Imaging; 2002 Oct; 20(8):619-22. PubMed ID: 12467871
[TBL] [Abstract][Full Text] [Related]
32. Proton MR spectroscopy of the brain in 14 patients with Parkinson disease.
Bowen BC; Block RE; Sanchez-Ramos J; Pattany PM; Lampman DA; Murdoch JB; Quencer RM
AJNR Am J Neuroradiol; 1995 Jan; 16(1):61-8. PubMed ID: 7900603
[TBL] [Abstract][Full Text] [Related]
33. Drug-induced parkinsonism in relation to choline-containing compounds measured by 1H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia.
Yamasue H; Fukui T; Fukuda R; Kasai K; Iwanami A; Kato N; Kato T
Int J Neuropsychopharmacol; 2003 Dec; 6(4):353-60. PubMed ID: 14604450
[TBL] [Abstract][Full Text] [Related]
34. Proton magnetic resonance spectroscopy in children with temporal lobe epilepsy.
Cross JH; Connelly A; Jackson GD; Johnson CL; Neville BG; Gadian DG
Ann Neurol; 1996 Jan; 39(1):107-13. PubMed ID: 8572655
[TBL] [Abstract][Full Text] [Related]
35. Seizure frequency and bilateral temporal abnormalities: a proton magnetic resonance spectroscopy of temporal lobe epilepsy.
Someya Y; Obata T; Suhara T; Ota Y; Ikehira H; Tanada S; Hirakawa K; Okubo Y; Sasaki Y
Seizure; 2000 Jun; 9(4):274-9. PubMed ID: 10880288
[TBL] [Abstract][Full Text] [Related]
36. [Proton magnetic-resonance spectroscopy in remitting and secondary-progressive multiple sclerosis].
Pozdniakov AV; Tiutin LA; Bisaga GN; Odinak MM
Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(4):36-9. PubMed ID: 11490432
[TBL] [Abstract][Full Text] [Related]
37. Reduced N-acetylaspartate in the brain observed on in vivo proton magnetic resonance spectroscopy in patients with mental retardation.
Hashimoto T; Tayama M; Miyazaki M; Yoneda Y; Yoshimoto T; Harada M; Miyoshi H; Tanouchi M; Kuroda Y
Pediatr Neurol; 1995 Oct; 13(3):205-8. PubMed ID: 8554657
[TBL] [Abstract][Full Text] [Related]
38. Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging.
Cendes F; Andermann F; Dubeau F; Matthews PM; Arnold DL
Neurology; 1997 Dec; 49(6):1525-33. PubMed ID: 9409340
[TBL] [Abstract][Full Text] [Related]
39. Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy.
Clarke CE; Lowry M
Eur J Neurol; 2000 Nov; 7(6):661-5. PubMed ID: 11136352
[TBL] [Abstract][Full Text] [Related]
40. Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging.
Bertolino A; Kumra S; Callicott JH; Mattay VS; Lestz RM; Jacobsen L; Barnett IS; Duyn JH; Frank JA; Rapoport JL; Weinberger DR
Am J Psychiatry; 1998 Oct; 155(10):1376-83. PubMed ID: 9766769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
